| Registrars: | Capita Registrars |
| CFO: | Gerald Desler |
| Chief Executive Officer : | Mark Eccleston |
| Non-Executive Chairman: | Martin Gouldstone |
| Non-Executive Dir: |
| Address: | 20 Wenlock Road, London, England,United Kingdom, N1 7GU |
| Website: | http://www.valirx.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BLH13C52 |
| Currency | UK Pounds |
| Share Price | 0.16p |
| Change Today | 0.005p |
| % Change | -3.13 % |
| 52 Week High | 0.42p |
| 52 Week Low | 0.13p |
| Volume | 1,260,091 |
| Shares Issued | 1,320.30m |
| Market Cap | £2.05m |
| RiskGrade | 435 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:15 | 500,000 @ 0.15p |
| 16:04 | 200,000 @ 0.16p |
| 16:04 | 210,000 @ 0.16p |
| 13:56 | 41,969 @ 0.15p |
| 11:02 | 183,196 @ 0.15p |
You are here: research